• Royalty Pharma EVP and CFO Terrance P. Coyne sold 64,399 Class A ordinary shares on May 26.
• Sale price was USD 53.98 per share; holding in TPC RP EPA1 LLC fell to zero.
• He reported continued beneficial ownership of 1,500 shares directly; 48,890 shares indirectly via IRAs and spouse holdings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001814876-26-000022), on May 28, 2026, and is solely responsible for the information contained therein.